DoD awards $2.79B pharmacy contract to Express Scripts, highlighting long-term fixed-price incentive arrangements

Contract Overview

Contract Amount: $2,792,812,526 ($2.8B)

Contractor: Express Scripts Inc

Awarding Agency: Department of Defense

Start Date: 2008-06-27

End Date: 2015-04-30

Contract Duration: 2,498 days

Daily Burn Rate: $1.1M/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 5

Pricing Type: FIXED PRICE INCENTIVE

Sector: Healthcare

Official Description: AWARD OF CONTRACT

Place of Performance

Location: SAINT LOUIS, SAINT LOUIS County, MISSOURI, 63121

State: Missouri Government Spending

Plain-Language Summary

Department of Defense obligated $2.79 billion to EXPRESS SCRIPTS INC for work described as: AWARD OF CONTRACT Key points: 1. Contract value suggests significant scale of pharmacy benefit management services for the Defense Health Agency. 2. Fixed-price incentive contract type indicates a shared risk/reward structure between the government and contractor. 3. Contract duration of nearly 7 years points to a stable, long-term relationship for essential healthcare services. 4. The award was made under full and open competition, suggesting a robust bidding process. 5. Contractor's extensive experience in pharmacy benefit management is likely a key factor in performance. 6. The scale of this award may influence market dynamics for similar large-scale federal healthcare contracts.

Value Assessment

Rating: good

The $2.79 billion award over nearly 7 years represents a substantial investment in pharmacy services. While specific pricing details and benchmarks are not provided, the fixed-price incentive structure suggests an attempt to control costs while allowing for performance-based adjustments. Comparing this to other large-scale pharmacy benefit management contracts within the federal government or large private sector entities would be necessary for a definitive value assessment. The long-term nature implies a degree of confidence in the contractor's ability to deliver value over time.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

This contract was awarded through full and open competition, indicating that multiple bidders were likely considered. The presence of 5 bids suggests a competitive environment, which generally benefits price discovery and can lead to more favorable terms for the government. The specific details of the competition, such as the number of proposals received and the evaluation criteria, would provide further insight into the effectiveness of the bidding process.

Taxpayer Impact: Full and open competition typically leads to better pricing for taxpayers by encouraging multiple companies to offer their best terms. This process helps ensure that the government is not overpaying for services by leveraging market forces.

Public Impact

Beneficiaries include active duty military personnel, retirees, and their families who rely on prescription medications. Services delivered encompass the management and dispensing of pharmaceuticals through a network of pharmacies. Geographic impact is nationwide, covering all eligible beneficiaries of the Defense Health Agency. Workforce implications may include the need for pharmacists, technicians, and administrative staff to support the contract's execution.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for cost overruns if incentive targets are not met or if unforeseen circumstances arise.
Dependence on a single contractor for a critical healthcare service could pose a risk if performance falters.
Complexity of managing a nationwide pharmacy network requires robust oversight to ensure efficiency and compliance.

Positive Signals

Awarded through full and open competition, suggesting a competitive pricing environment.
Fixed-price incentive contract type aligns contractor and government interests towards cost efficiency and performance.
Long contract duration provides stability and predictability for essential healthcare services.
Contractor's established presence in pharmacy benefit management indicates potential for reliable service delivery.

Sector Analysis

The pharmaceutical benefit management sector is a critical component of the healthcare industry, managing prescription drug programs for various payers. This contract falls within the broader healthcare services market, specifically focusing on pharmacy operations and drug procurement. The size of this award is significant, reflecting the large number of beneficiaries served by the Defense Health Agency. Comparable spending benchmarks would involve analyzing other large federal or private sector contracts for PBM services.

Small Business Impact

The provided data does not indicate any specific small business set-aside provisions for this contract, nor does it detail subcontracting plans. Given the large scale and specialized nature of pharmacy benefit management, it is possible that subcontracting opportunities may exist for smaller firms providing ancillary services. However, the primary award to a large entity like Express Scripts suggests that the core services are likely handled by the prime contractor.

Oversight & Accountability

Oversight for this contract would primarily fall under the Defense Health Agency, with potential involvement from the Department of Defense's Inspector General. Accountability measures are likely embedded within the contract's performance standards and the fixed-price incentive structure. Transparency would be facilitated through contract reporting requirements and public contract databases, although detailed operational data may be considered sensitive.

Related Government Programs

TRICARE Pharmacy Program
Department of Veterans Affairs Pharmacy Benefits Management
Federal Employees Health Benefits Program Pharmacy Services

Risk Flags

Potential for cost overruns due to incentive structure
Dependence on a single large contractor for critical services
Complexity of managing a nationwide pharmacy network
Need for robust oversight to ensure performance and compliance

Frequently Asked Questions

What is this federal contract paying for?

Department of Defense awarded $2.79 billion to EXPRESS SCRIPTS INC. AWARD OF CONTRACT

Who is the contractor on this award?

The obligated recipient is EXPRESS SCRIPTS INC.

Which agency awarded this contract?

Awarding agency: Department of Defense (Defense Health Agency).

What is the total obligated amount?

The obligated amount is $2.79 billion.

What is the period of performance?

Start: 2008-06-27. End: 2015-04-30.

What is the historical spending pattern for pharmacy services under the Defense Health Agency prior to this award?

Analyzing historical spending is crucial for context. While the specific data for this award is $2.79 billion over approximately 7 years (2008-2015), understanding prior expenditures would reveal trends in drug costs, utilization, and the effectiveness of previous contract vehicles. For instance, if previous contracts were significantly smaller or structured differently (e.g., cost-plus), this award might represent an expansion of services or a shift towards a more cost-conscious model. Without prior data, it's difficult to ascertain if this award reflects increased demand, inflation, or improved cost-efficiency over time. A comparative analysis of spending per beneficiary over different contract periods would offer deeper insights into value evolution.

How does the fixed-price incentive (FPI) structure in this contract typically function, and what are its implications for cost control?

A Fixed-Price Incentive (FPI) contract establishes a target cost, target profit, and a price ceiling. The final price is adjusted based on the contractor's actual cost performance relative to the target cost. If the contractor's costs are lower than the target, both the government and the contractor share in the savings according to a pre-negotiated formula. Conversely, if costs exceed the target, the contractor bears a portion of the overrun up to the price ceiling. This structure incentivizes the contractor to control costs diligently, as their profit is directly linked to their cost performance. For the government, it offers a degree of cost certainty up to the ceiling while still allowing for potential savings if the contractor performs exceptionally well. The effectiveness hinges on realistic target setting and robust cost accounting by the contractor.

What specific performance metrics are likely included in this contract to ensure quality of service and patient satisfaction?

While the contract details are not fully public, performance metrics for a large pharmacy benefit management contract typically include measures related to prescription fulfillment accuracy, turnaround times, formulary compliance, drug utilization review, patient safety protocols, and network pharmacy accessibility. Patient satisfaction surveys are also common. For an FPI contract, these metrics would likely be tied to the incentive portion, meaning higher performance could lead to increased profit for the contractor, while failure to meet minimum standards could result in penalties or reduced profit. The Defense Health Agency would have specific requirements to ensure beneficiaries receive timely and appropriate access to medications.

What is the potential impact of this contract on the broader pharmaceutical supply chain and drug pricing?

A contract of this magnitude, awarded to a major pharmacy benefit manager like Express Scripts, can significantly influence the pharmaceutical supply chain and drug pricing. As a large purchaser, the contractor has considerable leverage to negotiate discounts and rebates with drug manufacturers. This leverage can lead to lower overall drug costs for the government. Furthermore, the volume of prescriptions managed under this contract can impact demand for specific drugs, potentially influencing manufacturer production and distribution strategies. The contract's terms regarding generic substitution and formulary management also play a role in shaping prescribing patterns and encouraging the use of lower-cost alternatives.

How does the contractor's track record and experience in managing large-scale pharmacy benefits inform the assessment of this award's risk?

Express Scripts is a well-established player in the pharmacy benefit management industry, with extensive experience serving both government and commercial clients. This track record suggests a lower inherent risk associated with operational execution, claims processing, network management, and regulatory compliance. Their experience likely includes navigating complex healthcare regulations, managing large member populations, and implementing cost-containment strategies. However, the sheer scale of this DoD contract still presents risks related to managing a vast network, ensuring consistent service quality across diverse geographic locations, and adapting to evolving healthcare policies and drug innovations. A thorough review of their past performance on similar contracts, including any past issues or disputes, would be essential for a comprehensive risk assessment.

Industry Classification

NAICS: Retail Trade › Health and Personal Care Stores › Pharmacies and Drug Stores

Product/Service Code: MEDICAL SERVICES › OTHER MEDICAL SERVICES

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Solicitation ID: H9400207R0004

Offers Received: 5

Pricing Type: FIXED PRICE INCENTIVE (L)

Evaluated Preference: NONE

Contractor Details

Parent Company: Priority Healthcare Distribution Inc. (UEI: 078461979)

Address: 1 EXPRESS WAY, SAINT LOUIS, MO, 63121

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $3,260,025,101

Exercised Options: $3,256,978,351

Current Obligation: $2,792,812,526

Contract Characteristics

Consolidated Contract: Yes

Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED

Cost or Pricing Data: NO

Timeline